Compare Keel Infrastructure Corp. Common Stock (KEEL) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keel Infrastructure Corp. Common Stock vs Eli Lilly And Co — how do they compare? Keel Infrastructure Corp. Common Stock trades at $3.08 (market cap $1.93B), while Eli Lilly And Co trades at $1,177.57 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 538.9× Keel Infrastructure Corp. Common Stock's market cap, and Eli Lilly And Co pays a 0.59% dividend while Keel Infrastructure Corp. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Keel Infrastructure Corp. Common Stock for 1 Days and Eli Lilly And Co for 93 Days on average.
| KEEL | LLY | |
|---|---|---|
Market Cap | $1.93B | $1.04T |
Volume | 30,868,523 | 3,064,878 |
Sector | Technology | Health |
52-Week High | $6.66 | $1.28K |
52-Week Low | $1.71 | $799.57 |
Typical Hold Time | 1 Days | 93 Days |
Enterprise Value | $2.25B | $1.09T |
Dividend Yield | — | 0.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,179.27, down 0.79% on the day, with a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 expectation. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing its market leadership.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include competitive pressures in the obesity drug market and execution challenges in scaling production. With a consensus price target of $1,350, representing ~14% upside, the stock offers growth potential but requires monitoring of pipeline progress and market dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Keel Infrastructure Corp. Common Stock
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
